EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY-NC-ND 4.0

Cost analysis of intrauterine balloon tamponade versus uterine artery embolization in the management of persistent postpartum hemorrhage

Lisanne R Bonsen iD, M Elske van den Akker-van Marle, Camila Caram-Deelder iD, Paul I Ramler iD, Christianne J M de Groot, Thijs Urlings, Thomas van den Akker iD, Johanna G van der Bom iD, Dacia D C A Henriquez iD, TeMpOH‐1 study group

International Journal of Gynecology & Obstetrics · 2025

DOI: 10.1002/ijgo.70149 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift International Journal of Gynecology & Obstetrics, 2025. Verfasst von Lisanne R Bonsen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Leiden University Medical Center, Leiden, the Netherlands. Hauptthemen laut MEDLINE: Postpartum Hemorrhage, Uterine Artery Embolization, Uterine Balloon Tamponade. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Stichting Sanquin Bloedvoorziening.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The aim of this study was to compare the cost of a strategy initially resorting to intrauterine balloon tamponade versus a strategy initially resorting to uterine artery embolization in the management pathway of persistent postpartum hemorrhage.

Methods

This was a propensity score–matched cohort study including women who were subsequently treated with (scenario 1) versus uterine artery embolization (scenario 2) in order to control PPH, defined as postpartum bleeding that was resistant to first‐line treatment. We compared these two scenarios in terms of cost. These were based on costs of intervention, blood products transfused, and intensive care unit admission. We calculated the mean cost difference between the scenarios per woman.

Results

The propensity score–matched cohort comprised 50 women per scenario. In scenario 1, intrauterine balloon tamponade was successful in 29 women (58%), with a mean cost per patient of €7060 (standard deviation [SD], €2846). In scenario 2, uterine artery embolization was successful in 42 women (84%), with mean cost per patient of €7122 (SD, €2918). In each scenario, six women (12%) underwent a peripartum hysterectomy. The difference in mean cost per woman between the two scenarios was €62 in favor of scenario 1.

Conclusion

There is a negligible difference in cost between scenarios in which women with PPH are initially managed with intrauterine balloon tamponade versus uterine artery embolization. Given the comparable cost and maternal outcomes, intrauterine balloon tamponade is a favorable treatment, considering its less invasive nature, practical considerations, and lower risk of complications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Postpartum HemorrhageUterine Artery EmbolizationUterine Balloon TamponadeHumansFemaleAdultPregnancyPropensity ScoreCosts and Cost AnalysisCohort Studies

Stichwörter der Autor:innen

cost analysisintrauterine balloon tamponadematernal morbidityperipartum hysterectomypostpartum hemorrhageuterine artery embolization

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Leiden University Medical Center, Leiden, the Netherlands.
  • Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, the Netherlands.
  • Department of Biomedical Data Sciences, Section Medical Decision Making, Leiden University Medical Centre, Leiden, the Netherlands.
  • Department of Obstetrics and Gynecology, Amsterdam UMC, Universiteit van Amsterdam, Amsterdam, the Netherlands.
  • Amsterdam Reproduction and Development Research Institute, Amsterdam, the Netherlands.
  • Department of Radiology, Haaglanden Medical Center, The Hague, the Netherlands.

ORCID-Profile: Lisanne R Bonsen, Camila Caram-Deelder, Paul I Ramler, Thomas van den Akker, Johanna G van der Bom, Dacia D C A Henriquez

Förderung

  • Stichting Sanquin Bloedvoorziening

Zitieren

APA

Bonsen, L. R., van den Akker-van Marle, M. E., Caram-Deelder, C., Ramler, P. I., de Groot, C. J. M., Urlings, T., van den Akker, T., van der Bom, J. G., Henriquez, D. D. C. A., & TeMpOH‐1 study group (2025). Cost analysis of intrauterine balloon tamponade versus uterine artery embolization in the management of persistent postpartum hemorrhage. International Journal of Gynecology & Obstetrics. https://doi.org/10.1002/ijgo.70149

Vancouver

Bonsen LR, van den Akker-van Marle ME, Caram-Deelder C, Ramler PI, de Groot CJM, Urlings T, et al. Cost analysis of intrauterine balloon tamponade versus uterine artery embolization in the management of persistent postpartum hemorrhage. International Journal of Gynecology & Obstetrics. 2025. doi:10.1002/ijgo.70149

BibTeX
@article{Bonsen2025,
  author = {Bonsen, Lisanne R and van den Akker-van Marle, M Elske and Caram-Deelder, Camila and Ramler, Paul I and de Groot, Christianne J M and Urlings, Thijs and van den Akker, Thomas and van der Bom, Johanna G and Henriquez, Dacia D C A and TeMpOH‐1 study group, TeMpOH‐1 study group},
  title = {Cost analysis of intrauterine balloon tamponade versus uterine artery embolization in the management of persistent postpartum hemorrhage},
  journal = {International Journal of Gynecology & Obstetrics},
  year = {2025},
  doi = {10.1002/ijgo.70149}
}
Kostenlos starten →